Bristol-Myers Squibb ^Investor

Celgene is a global biopharmaceutical company that focuses on discovering, developing, and commercializing innovative therapies for cancer and immune-inflammatory-related diseases. They have a strong emphasis on providing treatment options for patients with limited options. Celgene is involved in numerous clinical trials at major medical centers, studying compounds for various types of cancers and serious inflammatory diseases. Their goal is to improve the lives of patients by developing effective therapies and addressing unmet medical needs.